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Abstract
Background: Cronobacter, formerly known as Enterobacter sakazakii, is a food-borne pathogen known to cause
neonatal meningitis, septicaemia and death. Current diagnostic tests for identification of Cronobacter do not
differentiate between species, necessitating time consuming 16S rDNA gene sequencing or multilocus sequence
typing (MLST). The organism is ubiquitous, being found in the environment and in a wide range of foods,
although there is variation in pathogenicity between Cronobacter isolates and between species. Therefore to be
able to differentiate between the pathogenic and non-pathogenic strains is of interest to the food industry and
regulators.
Results: Here we report the use of Expectation Maximization clustering to categorise 98 strains of Cronobacter as
pathogenic or non-pathogenic based on biochemical test results from standard diagnostic test kits. Pathogenicity
of a strain was postulated on the basis of either pathogenic symptoms associated with strain source or
corresponding MLST sequence types, allowing the clusters to be labelled as containing either pathogenic or non-
pathogenic strains. The resulting clusters gave good differentiation of strains into pathogenic and non-pathogenic
groups, corresponding well to isolate source and MLST sequence type. The results also revealed a potential
association between pathogenicity and inositol fermentation. An investigation of the genomes of Cronobacter
sakazakii and C. turicensis revealed the gene for inositol monophosphatase is associated with putative virulence
factors in pathogenic strains of Cronobacter.
Conclusions: We demonstrated a computational approach allowing existing diagnostic kits to be used to identify
pathogenic strains of Cronobacter. The resulting clusters correlated well with MLST sequence types and revealed
new information about the pathogenicity of Cronobacter species.
Background
Cronobacter,f o r m e r l yk n o w na sEnterobacter sakazakii
[1], is a bacterial genus containing seven species [2,3] in
the family Enterobacteriacae; C. sakazakii, C. malonati-
cus, C. muytjensii, C. turicensis, C. dublinensis, C. uni-
versalis, and C. condimenti. The organism has received a
lot of attention recently due to its association with neo-
natal infections, especially meningitis, necrotizing enter-
ocolitis, septicaemia and subsequent death [4,5]. These
bacteria have been isolated from a wide range of food
stuffs [6-8], therefore it is important to be able to detect
Cronobacter species in food. For this purpose several
diagnostic tests exist. However, most of these tests make
no distinction as to the species of the bacteria. Not all
Cronobacter s p e c i e sa r ek n o w nt ob ep a t h o g e n i ct o
infants and can cause asymptomatic colonisation. The
strict microbiological criteria for the presence of Crono-
bacter in powdered infant formula (< 1 Cronobacter
cell/10 g) for intended age < 6 months [9] means it is of
great interest to differentiate between pathogenic and
non-pathogenic strains. Although a range of possible
virulence features (i.e. ompA, adhesins, iron-uptake
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reviewed elsewhere [10], their presence does not corre-
spond to clinical symptoms. Therefore, the identification
of further discriminating factors would be useful. Cur-
rently, to differentiate between species, it is necessary to
sequence either the 16S RNA subunit [11] or the MLST
genes [12]; the latter is required for searching the Cro-
nobacter MLST database [12,13]. There are 178 isolates
of Cronobacter recorded in the MLST database [13] at
the time of analysis (March 2011). Although it is known
that type 4 strains (ST 4) are associated with meningitis
[14], neither of the above methods is able to differenti-
ate between pathogenic and non-pathogenic strains,
they only identify individual species. Moreover, both
methods are time consuming compared with the use of
biochemical diagnostic test kits which take 4-18 hours
to produce results that can easily be interpreted.
For this reason we aimed to develop methods for
identifying which of the strains in the Cronobacter
genus are pathogenic based on data obtained from stan-
dard biochemical diagnostic tests. These tests were
those commonly used to identify Cronobacter isolates
and are used in their taxonomic description [2,3,11].
Here we used Expectation Maximization (EM) clustering
algorithm to divide the data on the basis of the bio-
chemical test results. Since the precise pathogenic status
of most Cronobacter strains is unknown, we considered
the resulting clusters as being pathogenic or not on the
b a s i so f( a )t h es o u r c ef r o mw h i c ht h es t r a i n sw e r ei s o -
lated and/or (b) MLST types previously associated with
pathogenic or non-pathogenic strains (see Materials and
Methods) and reference [14]. The clustering of the bio-
chemical test results was also examined for traits asso-
ciated with pathogenicity.
Results and Discussion
Clustering the dataset for Test 1 with the number of
clusters being 2, resulted in clusters 1 (p1 =0 . 2 6 )a n d2
(p2 = 0.74) containing 25 and 65 strains respectively (L
= -3.119; Table 1) where pi (i = 1, 2) is the probability
of cluster membership for a randomly chosen strain and
L is the maximum log likelihood (see Materials and
Methods). According to our hypothesis cluster 2 was
most likely to contain pathogenic strains since all ST 4
strains were assigned to this cluster. It is known that ST
4 strains are associated with the most serious pathogenic
states such as meningitis in infants [14]. Of the other
MLST types, ST 1 and 3 were placed exclusively with
the potentially non-pathogenic strains in cluster 1. ST 7
was split between two clusters with 7 of 11 strains in
the non-pathogenic grouping. All except one ST 8 strain
were predicted to be in the pathogenic cluster, as were
all of the ST 12 strains (Table 1). The group with
unspecified clinical source (22 strains) was divided
between the two clusters, indicating that not all clinical
isolates are likely to be pathogenic and this feature (iso-
lation of a strain from a clinical sample) alone by no
means allows us to infer pathogenicity of a strain. For
example, one clinical case, classified as non-pathogenic,
was obtained from a breast abscess and it is plausible
that this was a secondary infection although it is not
known if another infectious agent was isolated. Thus
t h i sm a yi n d e e db ean o n - p a t h o g e n i cs t r a i n .T w o
asymptomatic strains appeared in the pathogenic cluster;
o n eo ft h e s es t r a i n si sS T1 2a n dt h eo t h e rS T1 3 .S e v -
eral ST 12 strains are from clinical sources and it is
likely that all ST 12 strains will have similar pathogenic
characteristics. Therefore, we can speculate that these
strains could have caused an infection following a higher
ingested dose or a lower immune status.
Clustering for the Test 2 dataset gave two clusters in
which 84 strains (91% of the data) were in cluster 2 (p2
= 0.9) and eight strains (9% of the data) were in cluster
1( p1 =0 . 1 ,L = -6.44; Table 2). One strain of those in
cluster 1 was associated with a clinical diagnosis (ST 31)
and was likely to be pathogenic, as well as one ST 4
strain, with the remainder placed in cluster 2. The het-
erogeneity of MLST types in both clusters, as well as
the small number of strains in cluster 1, suggests that
the biochemical data in Test 2 is not sufficient to differ-
entiate between pathogenic and non-pathogenic strains.
To prove this, the EM algorithm was allowed to auto-
matically determine the number of clusters to assign the
data to (data not shown). As a result, only a single clus-
ter was produced indicating that the Test 2 data is not
sufficient to differentiate between Cronobacter strains.
C l u s t e r i n go ft h eT e s t3d a t a s e t( T a b l e3 )r e s u l t e di n
cluster 1 containing 40 instances (p1 = 0.61) and cluster
2c o n t a i n i n g2 5i n s t a n c e s( p2 =0 . 3 9 ,L =- 1 6 . 7 2 6 ) .T h e
majority of the ST 4 strains were grouped in the second
cluster, indicating that this cluster contains the poten-
tially pathogenic strains. However, all other MLST types
(with multiple strains available) were split between the
two clusters. ST 1 was mostly placed in the non-patho-
genic cluster, with one strain in cluster 2. ST 3 was split
evenly (three in each) between the two clusters. Most of
the ST 7 strains were found to be non-pathogenic with
just one strain being pathogenic. However, many strains
indicated as pathogenic in the Test 1 results (and also
Test 2) were placed in the larger potentially non-patho-
genic grouping. Based on the division of strains of the
same MLST type between clusters, it is likely that the
results of Test 3 are less accurate than Test 1 and Test
4( s e eb e l o w ) ,a l t h o u g hm a n yS T1a n dS T4s t r a i n s
appeared to be correctly assigned. Note that this test
has the fewest number of strains available; it is expected
that the availability of more data will greatly improve
the results of clustering using this diagnostic test data.
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0.44) and cluster 2 contained 43 strains (p2 = 0.56). The
clusters are shown in Table 4 (L = -2.598). This cluster-
ing assignment was successful at differentiating between
MLST types. ST 1 and 3 were placed entirely in the non-
pathogenic grouping (cluster 1) and with two exceptions
(strains 552, 553), the ST 4 strains were placed in cluster
2, allowing us to label the latter as the potentially patho-
genic cluster. All except two ST 7 strains (strains 515,
535) were placed in the non-pathogenic cluster. ST 8
strains were placed in the pathogenic cluster as were all
except one strain of ST 12 (strain 520). A more detailed
examination of the strains allocated to each cluster
showed that all strains labelled as pathogenic were posi-
tive for the inositol fermentation (Ino) test, whilst the
prospective non-pathogenic strains were negative for this
test. Although this is not conclusively shown by the result
of the Inositol test in Test 1 and Test 2, the Test 1 data
does indicate a bias towards strains with inositol fermen-
tation in the pathogenic cluster. This suggested that
either inositol fermentation was a requirement for patho-
genicity, or that the genetic locus conferring inositol fer-
mentation was linked to genes conferring pathogenic
traits. This latter conclusion was supported by the two
apparently pathogenic ST 4 strains which were negative
for inositol fermentation (strains 552 and 553): strain 552
was isolated from infant formula, but strain 553 was asso-
ciated with neonatal meningitis indicating pathogenesis.
It is probable that the inositol fermentation gene was lost
f r o mt h e s es t r a i n s ,b u tt h ep a t h o g e n i ct r a i t sa c q u i r e d
alongside it remained. It should be noted that this test is
different from the INO test in the Test 2 dataset, which
we removed from the analysis as it produces the same
result for all Cronobacter strains.
Table 1 Clusters from Test 1 dataset
Cronobacter species MLST type Cluster 1: potential non-pathogenic
Source (number of strains)
Cluster 2: potential pathogenic
Source (number of strains)
C. sakazakii 1 IF(4), C(1), MP(1), Faeces(1) IF(1)
C. sakazakii 3 IF(1), EFT(2), FuF(4), U(1)
C. sakazakii 4 C(9), IF(7), MP(1), Washing Brush(1), E(1), U(2)
C. sakazakii 8 C(1) C(6), IF(1)
C. sakazakii 12 C(3), U(1)
C. sakazakii 13 IF(1), C(1)
C. sakazakii 15 C(1)
C. sakazakii 16 Spices(1)
C. sakazakii 17 IF(1)
C. sakazakii 18 C(1)
C. sakazakii 21 F(1)
C. sakazakii 31 C(1)
C. sakazakii 35 Herbs(1)
C. sakazakii 40 F(1)
C. sakazakii 41 C(1)
C. malonaticus 7 C(5), F(1), Faeces(1) C(2), MP(1), WF(1)
C. malonaticus 10 Herbs(2)
C. malonaticus 11 C(1) C(2)
C. malonaticus 29 U(1)
C. turicensis 5 MP(1), Herbs(1), MP(1), C(2)
C. turicensis 19 U(1)
C. turicensis 32 IF(1)
C. turicensis 37 Herbs(1)
C. muytjensii 33 U(1)
C. muytjensii 34 U(1)
C. dublinensis 42 U(1)
C. dublinensis 43 U(1)
C. universalis 54 Freshwater(1)
Abbreviations: C: clinical, E: Environmental, EFT: Enteral Feeding Tube, F: Food, FuF: Follow up Formula, IF: Infant Formula, MP: Milk Powder, U: Unknown WF:
Weaning Food. Sources of isolation and strain numbers are given in full in Additional File 1.
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Aggregating the clustering assignments based on the
majority rule (two out of four) for the 48 strains which
have data available from all four tests resulted in the
clusters shown in Table 5. The results showed the
majority of ST 4 strains were placed in cluster 2. How-
ever, there was still splitting of ST 1, 3 and 7 strains
b e t w e e nt h et w oc l u s t e r s .T h e r ew e r ea l s oo n l y1 0o f
the 48 strains placed in the non-pathogenic category. It
w a sh y p o t h e s i s e dt h a tt h er e s u l t sf r o mT e s t2c o u l db e
skewing the results, as this test did not differentiate
between strains of different MLST sequence types.
Therefore we excluded this test from the consensus
clustering allowing 50 strains for which data was avail-
able from Tests 1, 3 and 4 to be analysed. Test 3 was
retained since many ST 1 and ST 4 strains appeared to
be correctly assigned. The results (Table 6) were similar
to those for clustering with Test 4 alone. All strains of
ST 1, 3 and 7 appeared in cluster 1 (the potential non-
pathogenic grouping). With two exceptions (strains 552,
553), the ST 4 strains were grouped in cluster 2 (poten-
tially pathogenic strains) along with the remainder of
MLST types. The consensus clustering of Tests 1, 3 and
4 datasets also showed the same correlation with inosi-
tol fermentation as the results for Test 4 alone.
The results of all four clustering analyses gave plausi-
b l ea s s i g n m e n t so ft h ed a t ai n t ot w oc l u s t e r s ,o n eo f
which has the propensity of being pathogenic and the
other one of being non-pathogenic. The various MLST
types were not divided equally between the clusters as
Table 2 Clusters from Test 2 dataset
Cronobacter species MLST
Type
Cluster 1: potential non-pathogenic
Source (number of strains)
Cluster 2: potential pathogenic
Source (number of strains)
C. sakazakii 1 IF(1) IF(4), C(1), MP(1), Faeces(1)
C. sakazakii 3 IF(1), FuF(4), WF(1), U(1)
C. sakazakii 4 IF(1) C(9), IF(6), MP(1), WF(1), E(1), Washing Brush(1), U(2)
C. sakazakii 8 C(7), IF(1)
C. sakazakii 9 WF(1)
C. sakazakii 12 C(1) C(2), WF(1), U(2)
C. sakazakii 13 C(1), IF(1)
C. sakazakii 15 C(1)
C. sakazakii 16 Spices(1)
C. sakazakii 17 IF(1)
C. sakazakii 18 C(1)
C. sakazakii 21 F(1)
C. sakazakii 31 C(1)
C. sakazakii 40 F(1)
C. sakazakii 41 C(1)
C. malonaticus 7 C(1) C(6), F(1), MP(1), WF(1), Faeces(1)
C. malonaticus 10 Herbs(2)
C. malonaticus 11 C(1) C(2)
C. malonaticus 29 U(1)
C. muytjensii 33 U(1)
C. muytjensii 34 U(1)
C. turicensis 37 Herbs(1)
C. turicensis 5 MP(1), Herbs(1), C(2)
C. turicensis 19 U(1)
C. turicensis 32 IF(1)
C. turicensis 35 Herbs(1)
C. dublinensis 36 U(1)
C. dublinensis 42 U(1)
C. dublinensis 43 U(1)
C. universalis 54 Freshwater(1)
For abbreviations in this table see footnote to Table 1. Sources of isolation and strain numbers are given in full in Additional File 1.
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Cronobacter species MLST Type Cluster 1: potential non-pathogenic
Source (number of strains)
Cluster 2: potential pathogenic
Source (number of strains)
C. sakazakii 1 IF(4), C(1), Faeces(1) MP(1)
C. sakazakii 3 IF(1), FuF(2) FuF(2), U(1)
C. sakazakii 4 C(5), IF(1), Washing Brush(1) C(3), IF(6), MP(1), E(1), U(1)
C. sakazakii 8 C(3) C(2)
C. sakazakii 9 WF(1)
C. sakazakii 12 U(1), WF(1) C(1)
C. sakazakii 13 C(1)
C. sakazakii 14 IF(1)
C. sakazakii 15 C(1)
C. sakazakii 16 Spices(150)
C. sakazakii 17 IF(1)
C. sakazakii 18 C(1)
C. sakazakii 21 F(1)
C. sakazakii 31 C(1)
C. malonaticus 7 C(2), WF(1), Faeces(1) C(1)
C. malonaticus 10 Herbs(1)
C. malonaticus 11 C(1)
C. turicensis 5 C(1) MP(1) C(1)
C. turicensis 19 U(1)
C. turicensis 32 Infant Food(1)
C. dublinensis 36 U(1)
C. dublinensis 38 U(1)
C. dublinensis 42 U(1)
C. universalis 54 Freshwater(1)
For abbreviations in this table see footnote to Table 1. Sources of isolation and strain numbers are given in full in Additional File 1.
Table 4 Clusters from Test 4 dataset
Cronobacter species MLST Type Cluster 1: potential non-pathogenic
Source(number of strains)
Cluster 2: potential pathogenic
Source (number of strains)
C. sakazakii 1 IF(5), C(1), Faeces(1)
C. sakazakii 3 IF(1), EFT(2), FuF(4), WF(1), U(1)
C. sakazakii 4 C(1), IF(1) C(8), IF(6), MP(1), WF(1), E(1), Washing Brush(1), U(2)
C. sakazakii 8 C(7), IF(1)
C. sakazakii 9 WF(1)
C. sakazakii 12 C(1) C(2), WF(1), U(1)
C. sakazakii 13 IF(1), C(1)
C. sakazakii 14 IF(1)
C. sakazakii 15 C(1)
C. sakazakii 16 Spices(1)
C. sakazakii 17 IF(1)
C. sakazakii 18 C(1)
C. malonaticus 7 C(6), F(1), WF(1), Faeces(1) C(1), MP(1)
C. malonaticus 10 Herbs(2)
C. malonaticus 11 C(2) C(1)
All strains in cluster 1 (non-pathogenic) are negative for inositol fermentation, all strains in cluster 2 are positive for inositol fermentation. For abbreviations in
this table see footnote to Table 1. Sources of isolation and strain numbers are given in full in Additional File 1.
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Page 5 of 10one would expect by chance alone. Our hypothesis that
strains with similar biochemical characteristics will have
similar pathogenicity seems to hold since strains with
pathogenic source isolates were grouped together
throughout, although there were a small number of
strains that were placed in the non-pathogenic cluster
whilst having putative pathogenic status. Strains with
the same MLST type were generally grouped together
indicating, as might be expected, that strains with the
same MLST type have similar biochemical
characteristics.
To further investigate the association of inositol fer-
mentation with pathogenicity, we examined the
annotated genome of C. sakazakii BAA-894 [Genbank:
CP000783] (strain 658) [15] for genes associated with
inositol fermentation. Whilst BAA-894 is ST 1 and
negative for inositol fermentation, this strain was iso-
lated from powdered formula associated with a clinical
outbreak [15] and therefore is likely to be a pathogenic
strain. The gene coding for inositol monophosphatase
[Genbank: ESA_00718, EC:3.1.3.25], which is annotated
in the KEGG database [16] as part of the inositol phos-
phate metabolism pathway [KEGG: esa00562], was
found in close proximity (approx 41 kb upstream) to a
predicted protein [Genbank: ESA_00756] which has
been identified in the BAA-894 genome and found in
Table 5 Consensus clustering generated from Tests 1-4 data
Cronobacter species MLST Type Cluster 1 potential non-pathogenic:
Source(number of strains)
Cluster 2 potential pathogenic:
Source (number of strains)
C. sakazakii 1 IF(3), C(1), Faeces(1) IF(1), MP(1)
C. sakazakii 3 IF(1), FuF(2) FuF(2), U(1)
C. sakazakii 4 IF(7), C(6), MP(1), E(1), U(1), Washing Brush(1)
C. sakazakii 8 C(5)
C. sakazakii 12 U(1)
C. sakazakii 13 C(1)
C. sakazakii 15 C(1)
C. sakazakii 16 C(1)
C. sakazakii 17 IF(1)
C. sakazakii 18 C(1)
C. malonaticus 7 C(1), Faeces(1) C(2), WF(1)
C. malonaticus 10 Herbs(1)
C. malonaticus 11 C(1)
All strains in cluster 1 (non-pathogenic) are negative for inositol fermentation, all strains in cluster 2 are positive for inositol fermentation. For abbreviations in
this table see footnote to Table 1. Sources of isolation and strain numbers are given in full in Additional File 1.
Table 6 Consensus clustering generated from Tests 1, 3 and 4 data
Cronobacter species MLST Type Cluster 1: potential non-pathogenic
Source (number of strains)
Cluster 2: potential pathogenic
Source (number of strains)
C. sakazakii 1 IF(4), C(1), MP(1), Faeces(1)
C. sakazakii 3 IF(1), FuF(4), U(1)
C. sakazakii 4 C(1), IF(1) C(7), IF(5), MP(1), E(1), Washing Brush(1), U(1)
C. sakazakii 8 C(5)
C. sakazakii 12 U(1)
C. sakazakii 13 C(1)
C. sakazakii 15 C(1)
C. sakazakii 16 Spices(1)
C. sakazakii 17 IF(1)
C. sakazakii 18 C(1)
C. malonaticus 7 C(3), Faeces(1), WF(1)
C. malonaticus 10 Herbs(1)
C. malonaticus 11 C(1)
All strains in cluster 1 (non-pathogenic) are negative for inositol fermentation, all strains in cluster 2 are positive for inositol fermentation. For abbreviations in
this table see footnote to Table 1. Sources of isolation and strain numbers are given in full in Additional File 1.
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Page 6 of 10two other meningitic strains of C. sakazakii (strains 701,
767) by hybridization with the BAA-894 genome [15].
Strains 701 and 767 are ST 4 and were associated with
fatal outbreaks, indicating this as a putative virulence
factor. This was also found to be in close proximity to
the zinc-containing metalloprotease locus characterized
by Kothary et al [17]. Also at a distance of approxi-
mately 82 kb upstream, was a prophage fragment, GR3
[Genbank:ESA_00604-ESA_00630], which contains
genes homologous to the Yersinia pseudotuberculosis
adhesion pathogenicity island, as well as genes identified
in strains 701 and 767 and the reference genome [Gen-
bank: BAA-894]. Despite BAA-894 being deficient for
inositol fermentation, the proximity of these genes to
inositol monophosphatase and their implication as puta-
tive virulence factors suggests that the inositol mono-
phosphate gene is associated with pathogenesis and
supports our hypothesis that inositol fermentation is
linked to the pathogenicity of Cronobacter species. The
lack of inositol fermentation in BAA-894 may be
explained by the loss of another gene, as yet unknown,
which also plays a crucial role in the inositol phosphate
metabolism pathway.
T h eg e n o m eo faC. turicensis strain [Genbank:
FN543093-FN543096, ST 19, strain 1211] has also been
sequenced [18]. No biotyping data exists for C. turicen-
sis strains. However, the original characterisation of the
C. turicensis species [2] showed that C. turicensis is
positive for inositol fermentation and the C. turicensis
strain sequenced contains the inositol monophosphatase
gene associated with pathogenesis. The majority of C.
turicensis strains were placed in the pathogenic cluster
i nT e s t s1a n d2 ,b u tn o ti nT e s t3( n od a t ao nC. turi-
censis is available for Test 4). The sequenced strain 1211
was pathogenic in Tests 1 and 2 (Tables 1 and 2).
Our clustering method has demonstrated that it is
possible to quickly differentiate between pathogenic and
non-pathogenic strains, and may lead to a quick and
easy diagnostic test that can reliably identify pathogenic
strains.
Conclusions
Here we have used Expectation Maximization clustering
to divide strains of Cronobacter into groups of patho-
genic and non-pathogenic strains based on the results of
diagnostic biochemical tests. The clustering assignments
showed promise, clearly dividing the data into two clus-
ters containing obviously pathogenic and non-patho-
genic strains, based on the source of isolate and the
MLST type of the strain. However, further experiments
characterising the pathogenicity of Cronobacter strains
are required to confirm the accuracy of the classifica-
tion. Nevertheless, our results demonstrated a clear
association between pathogenic strains and inositol fer-
mentation, supported by genomic proximity of putative
virulence factors to the gene coding for inositol
monophosphatase.
Methods
Sources of bacterial strains
At o t a lo f9 8Cronobacter strains were analyzed in this
study. Strains were from diverse food, clinical and envir-
onmental sources worldwide. The following species of
Cronobacter were included: C. sakazakii NCTC 11467
T,
C. malonaticus LMG 23826
T, C. turicensis LMG
23827
T, C. muytjensii ATCC 51329
T, C. dublinensis
LMG 23823
T, C. universalis NCTC 9529
T.S t r a i n sw e r e
kindly donated by the following organizations: Health
Products and Food Branch (Health Canada); CDC
(Atlanta, USA); Children’s Hospital (Los Angeles CA,
USA); Northern Foods (UK); Oxoid ThermoFisher Ltd.
(Basingstoke, UK); Hospital Cèské Budéjovice (Czech
Republic); Institut fûr Tierärztliche Nahrungsmittelk-
unde Milchwissenschaften (Justus-Liebig-Universität
Gießen, Germany); Nottingham City Hospital Trust
(Nottingham, UK) and the Department of Medical
Microbiology, Radboud (Nijmegen, Netherlands). All
other strains were food and environmental isolates from
the culture collection at Nottingham Trent University
(Nottingham, UK) [19].
Dataset
We examined results from four sets of diagnostic tests
carried out on a total of 98 strains encompassing six
species of Cronobacter. For a complete list of strains
used in this work and their details see Additional File 1
and references [[1-3,15,18] and [20-28]]. Each test com-
prises a series of enzyme assays which produce a colour
change recorded by the user. Bacterial species can then
be identified by a characteristic series of changes in col-
our. All tests were carried out in accordance with the
manufacturers’ instructions and replicated three times;
biotyping was performed as in [1]. The tests were those
commonly used in the identification of Cronobacter spe-
cies, and in taxonomic descriptions of the genus
[2,3,12,19].
The four tests were:
Test 1
API 20 E (bioMérieux; SA, Marcy-l’Etoile, France) [29]
consists of 20 enzyme assays scored as positive or nega-
tive. The assays are in the form of a strip of 20 cupules
each containing a dehydrated substrate to which the
reagents are added, for details of the specific tests see
[29] and the manufacturers’ instructions. Gram negative
bacterial species are identified by comparison to an
online database.
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ID 32E (bioMérieux SA; Marcy-l’Etoile, France) [30]
consists of 32 miniaturised enzyme assays with positive
or negative scores these assays can be measured either
manually or automatically and Gram negative bacterial
species are identified by comparison to an online
database.
Test 3
API Zym (bioMérieux SA; Marcy-l’Etoile, France) [31]
consists of 20 cupules with 19 enzyme assays and one
control. The assays produce a coloured response which
is scored in intensity between 0 and 5.
Test 4
Biotyping [1] is a series of biochemical tests for identify-
ing bacteria. Tests are carried out for: indole production
(Ind), motility at 36°C (Mot), acid production from i-
inositol (Ino), malonate utilization (Malo) ornithine-
Moellers (Orn), acid production from dulcitol (Dul),
Methyl Red test (MR), Voges-Proskauer (VP) test, gas
production (Gas), and nitrite metabolism (Nit). Details
of all tests are given in [1].
The results of each test were represented by a separate
dataset containing only the strains that have results for
that test. The Test 1, Test 2, Test 3 and Test 4 datasets
contained 91, 92, 65 and 76 strains respectively. There are
98 strains in total, 48 of these have data for all four tests.
Further, 31 only have data for three out of four tests, and
14 for only two out of four tests. It should be noted that
although there was a considerable overlap between the
datasets, each dataset was considered separately. Each
strain was identified by its isolate number retrieved from
the Cronobacter MLST database [13] as well as source,
geographical location and date of isolation. These attri-
butes were removed for the purpose of clustering but were
used to label the data afterwards. The result of each
enzyme assay was represented categorically. In the case of
Tests 1, 2 and 4 this was 0 or 1 for a negative or positive
result respectively. A positive result being one which
shows activity for the enzyme in the sample. Test 3 had
categories ranging from 0 to 5. 0 is indicative of no reac-
tion, and categories 1-5 indicate a range of positive
responses, with 5 being the strongest response. Thus, each
strain from each dataset was represented by a vector of
attributes with each attribute containing the result of one
of the enzyme assays in the corresponding test.
Features used
The enzyme assays used in this study were not designed
to discriminate between species or genotypes of Crono-
bacter. In all four tests there were assays where all (or
almost all) strains were reported as producing the same
result, either positive or negative. Attributes where all
strains produce the same result, either positive or nega-
tive, for Tests 1, 2 and 4 or where all strains occupy one
category in the case of Test 3 were removed from the list
of features used for clustering. The features from each
test used to perform clustering are listed in Table 7.
EM Clustering
Clustering was carried out using the Expectation Maxi-
mization (EM) algorithm [32] implemented in the
Weka machine learning package [33]. Whilst we give a
brief explanation of the algorithm here, the reader is
advised to consult the reference for full details. The
algorithm operates by using Gaussian mixture models
to estimating the maximum likelihood of membership
in a cluster. In Gaussian mixture models the data is
drawn from a mixture of k Gaussian distributions with
mean ui a n ds t a n d a r dd e v i a t i o nsi (1≤i≤k). The algo-
rithm begins by randomly selecting parameters ui and
si and computing the probability of cluster member-
ship for each data point based on the probability den-
sity function defined by parameters ui and si.T h e
distribution parameters are then re-estimated, the clus-
ter membership is recomputed and these steps are
repeated until a termination threshold is reached and/
or the procedure converges to a local maximum of the
likelihood function. For a two-component mixture
model used in this study the resulting probabilities of
a random strain being in class 1 and 2 were denoted
by p1 and p2 (p1+p2 = 1) respectively, the maximum of
log-likelihood estimate was denoted by L.
The following initial parameters for the EM algorithm
were used: the maximum number of iterations was set
to 100, the minimum standard deviation was set to
1.0E-06, and the number of clusters was set to 2.
Table 7 Features used for clustering in each set of biochemical tests
Attributes Used Attributes Removed
Test 1: LDC, ODC, CIT, URE, TDA, IND, VP, GEL, MAN, INO, SOR, RHA, SAC Test1: ONPG, H2S, GLU, MEL,
AMY, ARA, OX,
Test2: GAL, ACT, SAC, NAG, LAT, ARA, CEL, RAF, MAL, TRE, 2KG, MDG, SOR, XYL, RIB, GLY, RHA, PLE, ERY, MEL, GRT,
MLZ, GNT, LVT, MAN, LAC, GLU, SBE, GLN, ESC
Test2: INO
Test3: Alkaline Phosphatase, Esterase, Esterase Lipase, Lipase, Leucine arylamidase, Valine arylamidase, Cystine
arylamidase, Trypsin, a-chymotrypsin, Acid phosphatise, Naphthhol-AS-BI-phosphohydrolase, a-galactosidase, b-
galactosidase, b-glucuronidase, a-glucosidase, b-glucosidase, N-acetyl- b-glucosaminidase, a-mannosidase, a-
fucosidase
Test3: None
Test4:VP, MR, Nit, Orn, Mot, Ino, Malo, Gas Test4: Dul, Ind
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Page 8 of 10The number of clusters was pre-specified for all experi-
ments in this work; we set the number of clusters to two
as we were seeking to split the data into pathogenic and
non-pathogenic groups. Evaluation of the pathogenicity
of the resulting clusters was somewhat subjective since
the pathogenic status of the majority of Cronobacter
strains was not known. However, some samples were
clearly the source of pathogenic effects such as meningi-
tis or septicaemia. There was evidence that strains with
MLST sequence type (ST) 4 cause the most severe infec-
tions [14]. This was supported by the fact that all except
two of ten strains that demonstrated clinical diagnosis
were ST 4. Since strains with similar biochemical proper-
ties are likely to have similar pathogenic status, it was
hypothesised that if the majority of ST 4 strains are
placed into one cluster then this cluster is likely to be
pathogenic whereas the remaining cluster is likely to be
non-pathogenic. Therefore we designated the cluster
with the largest number of ST 4 strains as pathogenic.
Since it is reasonable to assume that similar MLST
types will have similar levels of pathogenicity, the spec-
trum of MLST types in each cluster is a good indicator
of the accuracy of the assignment, and takes into
account factors such as differences between species of
Cronobacter. To date only a few plausible virulence fea-
tures have been identified, such as ompA, adhesins, and
iron-uptake mechanisms, many of which are distributed
across the seven Cronobacter species [10].
Consensus clustering
Consensus clustering was carried out to combine the
results generated by the four tests. It was hypothesised
t h a tt h ec o n s e n s u sc l u s t e r i n gw i l lr e s u l ti nam o r ea c c u -
rate classification of strains in the appropriate cluster.
The four clustering assignments were combined by way
of each assignment having one vote with the majority
determining the cluster assignment of each strain. Any
tie (i.e. two of four votes for each cluster) in the voting
resulted in the strain being placed in the pathogenic clus-
ter; this decreased the probability of missing a pathogenic
strain while increasing the risk of finding a false positive.
However, this was accepted as a good compromise, since
missing a pathogenic strain has more serious conse-
quences than misidentifying a negative strain. The con-
sensus clustering was carried out on the 48 strains for
which data for all four diagnostic tests is available.
Additional material
Additional File 1: Cronobacter strains. Strains used in this study
including source of isolation, MLST Type, references and which
experiments they were used in.
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